Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/4/2020
SIETES contiene 92957 citas

 
 
 1 a 20 de 425 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby J-F, Tricoci P, White HD, Zeiher AM, for the ODYSSEY OUTCOMES Committees and Investigators. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med 2018;379:29 de noviembre. [Ref.ID 102917]
2. Cita con resumen
Tegn N, Abdelnoor M, Aaberge L, Endresen K, Smith P, Aakhus S, Gjertsen E, Dahl-Hofseth O, Ranhoff AH, Gullestad L, Bendz B, After Eighty study investigators. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial. Lancet 2016;387:1057-65. [Ref.ID 100152]
3. Cita con resumen
Pfeffer MA, Clagget B, Diaz R, Dickstein K, Gerstein HC, Kober LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC, ELIXA Investigators. Lixisenatide in patients with type 2 diabetes and acute coronary syndrome. N Engl J Med 2015;373:2247-57. [Ref.ID 99794]
4.Enlace a cita original Cita con resumen
Kivimäki M, Jokela M, Nyberg ST, Singh-Manoux A, Fransson EI, Alfredsson L, Bjorner JB, Borritz M, Burr H, Casini A, Clays E, De Bacquer D, Dragano N, Erbel R, Geuskens GA, Hamer M, Hooftman WE, Houtman IL, Jöckel K-H, Kittel F, Knutsson A, Koskenvuo M, Lunau T, Madsen IEH, Nielsen ML, Nordin M, Oksanen T, Pejtersen JH, Pentti J, Rugulies R, Salo P, Shipley MJ, Siegrist J, Steptoe A, Suominen SB, Theorell T, Vahtera J, Westerholm PJM, Westerlund H, O'Reilly D, Kumari M, Batty GD, Ferrie JE, Virtanen M, IPD-Work Consortium. Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603 838 individuals. Lancet 2015;386:1739-46. [Ref.ID 99622]
6.Tiene citas relacionadas
Wiviott SD, Steg PG. Clinical evidence for oral antiplatelet therapy in acute coronary syndromes. Lancet 2015;386:292-302. [Ref.ID 99357]
8. Cita con resumen
del Castillo-Carnevali H, Barrios Alonso V, Zamorano Gómez JL. Antiagregación: resistencia a fármacos tradicionales y papel de los nuevos antiplaquetarios. Med Clin (Barc) 2014;143:222-9. [Ref.ID 97903]
9. Cita con resumen
Anónimo. Rivaroxaban 2,5 mg. Prescrire 2014;34:326-9. [Ref.ID 97554]
10. Cita con resumen
Lincoff AM, Tardif JC, Schwartz GG, Nicholls SJ, Rydén L, Neal B, Malmberg K, Wedel H, Buse JB, Henry RR, Weichert A, Cannata R, Svensson A, Volz D, Grobbee DE, for the AleCardio Investigators. Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus. The AleCardio randomized clinical trial . JAMA 2014;311:1515-25. [Ref.ID 97381]
15. Cita con resumen
Roe MT, Ohman EM. A new era in secondary prevention after acute coronary syndrome. N Engl J Med 2012;365:85-7. [Ref.ID 92105]
16. Cita con resumen
Mega JL, Braunwald E, Wiviott SD, Bassand J-P, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KAA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FWA, Gibson CM, for the ATLAS ACS 2-TIMI 51 Investigators. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med 2012;366:9-19. [Ref.ID 92103]
17.Tiene citas relacionadas
Alexander JH, Lopes RD, Wallentin L. Apixaban after acute coronary syndrome. N Engl J Med 2011;365:1845. [Ref.ID 91648]
18.Tiene citas relacionadas
Fauchier L, Clementy N. Apixaban after acute coronary syndrome. N Engl J Med 2011;365:1844. [Ref.ID 91647]
19. Cita con resumen
Roe MT, Ohman EM. A new era in secondary prevention after acute coronary syndrome. N Engl J Med 2011;365:85-7. [Ref.ID 91611]
20.Enlace a cita original
Anónimo. NICE Guidance - October 2011. Prescribing Advice for GPs 2011:octubre. [Ref.ID 91579]
Seleccionar todas
 
 1 a 20 de 425 siguiente >>